STAT Plus: More hospital drug spending is going toward cancer immunotherapies
ADOBE
There was a 199% rise in spending for small cell lung cancer drugs during the first three quarters of this year compared with the same period in 2018.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario